Author:
Teranishi Junya,Nagatoya Katsuyuki,Kakita Tomoko,Yamauchi Yoko,Matsuda Hirohisa,Mori Tatsuhiko,Inoue Toru
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference15 articles.
1. Isobe K, Muraoka S, Sugino K, Yamazaki Y, Kikuchi N, Hamanaka N, et al. Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy. Nihon Kokyuki Gakkai Zasshi. 2007;45:489–93. (in Japanese).
2. Peman J, Salavert M, Canton E, Jarque I, Roma E, Zaragoza R, et al. Voriconazole in the management of nosocomial invasive fungal infections. Ther Clin Risk Manag. 2006;2:129–58.
3. Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB. Voriconazole. Clin Ther. 2003;25:1321–81.
4. Johnson LB, Kauffman CA. Voriconazole. A new triazole antifungal agent. Clin Infect Dis. 2003;36:630–7.
5. Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs. 2004;64:1997–2020.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献